BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2001
View Archived Issues
Renewed focus on oncology products at Transgene
Read More
AltaRex reports 2000 update
Read More
Clinical data reported for an optimized Theratope vaccine formulation
Read More
Pharmagenesis establishes development teams for two cancer treatment drug candidates
Read More
Cypress Bioscience and Georgetown collaborate on treatment for fibromyalgia syndrome
Read More
FDA supports Vical's Allovectin-7 clinical development program
Read More
Apomate begins phase II evaluation for cancer detection
Read More
Genelabs presents DNA-binding antifungal agents
Read More
Aventis creates new Gencell entity and restructures alliance with Introgen
Read More
Herceptin receives Japanese approval for treatment of metastatic breast cancer
Read More
Carboxypeptidase A-activated antifolate prodrug identified by Dana-Farber
Read More
DuPont identifies small-molecule TACE inhibitors for inflammation, autoimmune diseases
Read More
Orphan drug designation granted in Europe for Trisenox
Read More
Traditional Chinese medicinal formulation useful for alleviating toxicity of chemotherapy
Read More
FDA approves Celltech's once-daily ADHD treatment
Read More
New topoisomerase I-interactive fluoroindolocarbazole presented by BMS at AACR meeting
Read More
Antisense approaches to diabetes discussed at ACS by Isis
Read More
Launch announced for Viadur for advanced prostate cancer
Read More
Ark Therapeutics obtains positive results in EG-009 phase I/IIa trial
Read More
GSK discusses discovery and SAR for new series of dual PPARgamma/PPARalpha activators
Read More
Sch-62373, a dual NK1/NK2 antagonist from a series of 2-phenylpiperazines
Read More
New TAP anticancer therapeutic CPI-0004Na: design and synthesis reported this week
Read More
Sankyo presents new tachykinin antagonists and potential uses
Read More
Novel naturally produced compound is selective against H. pylori
Read More
Muscarinic M3-selective antagonists designed at Banyu
Read More
Thiophene NPY Y5 receptor ligands useful for eating and other disorders
Read More
Meiji Seika reports new series interacting with 5-HT4 receptors
Read More
Japanese patent covers preparation and use of beta3-adrenoceptor agonists
Read More